KORU Medical Systems, Inc.

NASDAQ:KRMD

Medical - Instruments & Supplies

Healthcare
$3.45 +1.55%

+$0.06 today

Market cap
$149.64M
Beta
0.42
P/E (TTM)
-80.2
EPS (TTM)
-$0.05
52W Low $2.91High $6.61

Volume 0.19M

Average 0.13M

KRMD Debt Repayment

Cash used to repay borrowings during the period.

KORU Medical Systems, Inc.NASDAQ: KRMD

Debt Repayment · Q1 FY2026 · quarter ended Mar 2026

Debt repayment growth accelerates

Q1 FY2026 debt repayment of $29.22K (cash outflow) rose 8.9% year over year, ahead of the +3.0% change in trailing-twelve-month debt repayment. Sequentially, it fell 91.9% from the prior quarter. Over 3 fiscal years it compounded at +44.0% a year.

Context

  • Debt repayment amounted to 0.9% of revenue in FY2025, up 0.6 pp from a year earlier.
  • Debt repayment grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +8.9% holds above the trailing-twelve-month pace of +3.0%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$29.22K-91.9% QoQ
Last fiscal yearDec 2025
-$379.98K+252.0% YoY
LTMMar 2026
-$111.21K+3.0% YoY
Debt Repayment past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+8.9%——
1 year+252.0%——
3-year CAGR+44.0%——
5-year CAGR——
10-year CAGR——

Debt Repayment history

USD · from the cash flow

Latest · FY2025
(379.98K) USD
Year-over-year change
-252.0%

Debt Repayment vs competitors

How KRMD compares with its peers on the latest reported figures

  • Peers report in different currencies, so debt repayment is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +3.0% is the 4th highest of 7, against a peer median of +52.7%.
  • Debt repayment amounts to 0.3% of revenue for KRMD, versus a peer median of 3.0%.
KRMD Competitors
Debt Repayment for KRMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PREPrenetics Global LimitedLTM Mar 2026$40.01M USD——35.2%
NYXHNyxoah S.A.LTM Mar 2026€21.45M EUR+154.4%—131.5%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$9.13M USD+601.4%+592.6%6.4%
STIMNeuronetics, Inc.LTM Mar 2026$4.62M USD+283.3%—3.0%
PROFProfound Medical Corp.LTM Mar 2026$1.03M USD-48.9%—5.4%
KRMDKORU Medical Systems, Inc.LTM Mar 2026$111.21K USD+3.0%+44.0%0.3%
OSUROraSure Technologies, Inc.LTM Mar 2026$70K USD-91.3%-64.7%0.1%
TLSITriSalus Life Sciences, Inc.LTM Mar 2026$19K USD-100.1%—0.0%
UTMDUtah Medical Products, Inc.LTM Mar 2026$0 USD——0.0%
MXCTMaxCyte, Inc.LTM Mar 2026$0 USD——0.0%
Peer median (excluding KRMD) —+52.7%+264.0%3.0%

Competitors are the stored peer set for KRMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(4.56M)(8.66M)(13.74M)(6.07M)(2.64M)
Depreciation & Amortization463.13K587.14K870.39K888.47K810.5K
Deferred Income Tax(1.82M)(2.03M)3.97M00
Stock-Based Compensation2.71M3.08M2.77M2.62M2.71M
Change in Working Capital(1.11M)1.4M1.2M1.97M(319.17K)
Accounts Receivables(1.74M)(220.17K)457.18K(1.68M)(489.2K)
Inventory723.43K(298.53K)2.92M677.63K(874.46K)
Accounts Payables602.61K1.16M(1.42M)674.78K617.5K
Other Working Capital(698.28K)758.15K(760.19K)2.3M426.99K
Other Non-Cash Items(1.01K)212.55K37.82K259.55K(104.54K)
Operating Cash Flow(4.32M)(5.4M)(4.89M)(319.72K)462.41K
Capital Expenditures(375.23K)(2.8M)(814.6K)(1.3M)(932.52K)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(19.99K)(40.51K)(31.65K)(35.62K)(17.27K)
Investing Cash Flow(366.17K)(2.8M)(814.6K)(1.33M)(949.79K)
Debt Repayment505.94K(127.14K)(218.87K)(107.96K)(379.98K)
Common Stock Issued2.2M406.62K00186.17K
Common Stock Repurchased000(97.38K)0
Dividends Paid00000
Other Financing Activities000(43.19K)(27.54K)
Financing Cash Flow2.71M279.49K(218.87K)(248.53K)(221.35K)
Effect of Forex Changes00000
Net Change in Cash(1.98M)(7.93M)(5.93M)(1.9M)(708.74K)
Free Cash Flow(4.69M)(8.21M)(5.71M)(1.62M)(470.11K)

KORU Medical Systems, Inc.

NASDAQ:KRMD

Intrinsic Alpha fair value

Locked

Current Price

$3.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.